$EXEL rating summary very bullish. Unbelievable undervalued stock with strong balance 1.4in cash and great pipeline. It’s time for big pharm to acquire this company now before is to late. @Roche ⁦@JNJInnovation⁩ ⁦@JanssenUS⁩ ⁦@bmsnews⁩ ⁦$PFE $Mrk $AMGN $ABBV https://t.co/BAZcORrdVH